[1] |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. |
|---|
| Authors : Lip Gregory Y H GY; Huber Kurt K; Andreotti Felicita F; Arnesen Harald H; Airaksinen K Juhani KJ; Cuisset Thomas T; Kirchhof Paulus P; Marín Francisco F; ; |
| Affiliation : University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, United Kingdom. g.y.h.lip@bham.ac.uk |
| Journal : Thromb. Haemost. (2010) |
| Related Links: Pubmed | Publisher website |
| Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis |
| Authors : Lip GY; Andreotti F; Fauchier L; Huber K; Hylek E; Knight E; Lane DA; Levi M; Marin F; Palareti G; Kirchhof P; Document reviewers:; Collet JP; Rubboli A; Poli D; |
| Affiliation : University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK. g.y.h.lip@bham.ac.uk Tel: +44 121 5075080; Fax: +44 121 507 4907; Email: g.y.h.lip@bham.ac.uk |
| Journal : Eurpopace (2011) |
| Related Links: Pubmed | Publisher website |

